Results 11 to 20 of about 8,844 (171)

Anthrax Toxin Characterization [PDF]

open access: yesActa Medica, 2002
The anthrax toxin comprises three proteins. When they work together, they can kill humans, especially after spores of the bacteria have been inhaled.
Jiří Patočka, Miroslav Špliňo
doaj   +3 more sources

Cytoskeleton as an Emerging Target of Anthrax Toxins [PDF]

open access: yesToxins, 2012
Bacillus anthracis, the agent of anthrax, has gained virulence through its exotoxins produced by vegetative bacilli and is composed of three components forming lethal toxin (LT) and edema toxin (ET).
Jean-Nicolas Tournier, Yannick Trescos
doaj   +3 more sources

Anthrax Toxin: A Pioneer of Targeted Protein Toxins. [PDF]

open access: yesToxins (Basel)
With anthrax toxin as a pioneer, several bacterial toxins have been engineered to deliver proteins of interest into the cytosol of specific mammalian cells. Such targeted protein toxins combine the ability to deliver cargo molecules into cells with designed receptor interaction for targeting selected cells.
Richter S, Schmidt G.
europepmc   +3 more sources

Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors. [PDF]

open access: yesPLoS ONE, 2011
Anthrax toxin is the major virulence factor produced by Bacillus anthracis. The toxin consists of three protein subunits: protective antigen (PA), lethal factor, and edema factor.
Chenguang Cai   +8 more
doaj   +1 more source

Evidence against a human cell-specific role for LRP6 in anthrax toxin entry. [PDF]

open access: yesPLoS ONE, 2008
The role of the cellular protein LRP6 in anthrax toxin entry is controversial. Previous studies showed that LRP6 was important for efficient intoxication of human M2182 prostate carcinoma cells but other studies performed with cells from gene-knockout ...
Patricia L Ryan, John A T Young
doaj   +1 more source

A Comparison of the Adaptive Immune Response between Recovered Anthrax Patients and Individuals Receiving Three Different Anthrax Vaccines. [PDF]

open access: yesPLoS ONE, 2016
Several different human vaccines are available to protect against anthrax. We compared the human adaptive immune responses generated by three different anthrax vaccines or by previous exposure to cutaneous anthrax.
Thomas R Laws   +14 more
doaj   +1 more source

Anthrax toxin requires ZDHHC5-mediated palmitoylation of its surface-processing host enzymes [PDF]

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2019
Oksana Sergeeva   +2 more
exaly   +2 more sources

Disulfide bonds in the ectodomain of anthrax toxin receptor 2 are required for the receptor-bound protective-antigen pore to function. [PDF]

open access: yesPLoS ONE, 2010
Cell-surface receptors play essential roles in anthrax toxin action by providing the toxin with a high-affinity anchor and self-assembly site on the plasma membrane, mediating the toxin entry into cells through endocytosis, and shifting the pH threshold ...
Jianjun Sun, R John Collier
doaj   +1 more source

Anthrax lethal and edema toxins in anthrax pathogenesis [PDF]

open access: yesTrends in Microbiology, 2014
The pathophysiological effects resulting from many bacterial diseases are caused by exotoxins released by the bacteria. Bacillus anthracis, a spore-forming bacterium, is such a pathogen, causing anthrax through a combination of bacterial infection and toxemia. B.
Shihui, Liu   +2 more
openaire   +2 more sources

Delayed toxicity associated with soluble anthrax toxin receptor decoy-Ig fusion protein treatment. [PDF]

open access: yesPLoS ONE, 2012
Soluble receptor decoy inhibitors, including receptor-immunogloubulin (Ig) fusion proteins, have shown promise as candidate anthrax toxin therapeutics.
Diane Thomas   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy